Influenza Vaccination
Influenza Vaccination
复制标题
DOI：
10.1056/nejmcp1512870
复制
发表时间：
2016-09-29
影响因子：
158.5
通讯作者：
Treanor, John J.
中科院分区：
文献类型：
--
作者：
Treanor, John J.
一位75岁的男性，高血压和轻度慢性阻塞性肺病控制良好，但其他方面都很健康，在初秋去看医生。他对接种流感疫苗有疑问。他特别问他是应该接种标准剂量的四组分疫苗，还是最近批准的只有三组分的高剂量疫苗。你有什么建议？疫苗能降低流感风险的证据有多充分？
A 75-year-old man who has well-controlled hypertension and mild chronic obstructive pulmonary disease, but who is otherwise healthy, visits his physician in the early fall. He has questions about vaccination against influenza. He asks specifically whether he should receive a standard-dose four-component vaccine or the recently licensed high-dose vaccine, which has only three components. What would you advise, and how strong is the evidence that a vaccine will reduce his risk of influenza?